|
Big Data Study Identifies New Potential Target Coating For Drug-Eluting Stents
|
|
New Study Evaluates the Safety and Efficacy of Biodegradable Polymer-coated Sirolimus-eluting Stents in Patients with Coronary Artery Disease
|
|
Randomized Study Demonstrates the Superiority of Laser Atherectomy for Treatment of In-stent Restenosis in Patients with Femoropopliteal Peripheral Artery Disease
|
|
New All-Comers Study Compares Efficacy of Bioresorbable Vascular Scaffold to Best-in-class Drug-Eluting Stents
|
|
New Study Finds Systemic Hypothermia Does Not Improve Outcomes for Heart Attack Patients
|
|
Large Study Offers Real World Comparison of Blood Thinner Use in Heart Attack Patients
|
|
New Study Examines the Optimal Duration Time of Dual Anti-platelet Therapy in Patients with Second-generation Drug-eluting Stents
|
|
New Study Evaluates “Triple Therapy” Regimens after Drug-eluting Stenting in Patients Requiring Oral Anticoagulation
|
|
Extended Follow-up of Multicenter Trial Demonstrates Continued Superiority of Bivalirudin to Heparin with and Without Glycoprotein IIb/IIIa Inhibition in Patients with Acute Myocardial Infarction
|
|
New Study Finds Everolimus-Eluting Stents Provide Superior Clinical Outcomes Compared to Drug-Eluting Balloons with Drug-Eluting Stent Restenosis
|
